To ensure fair and global access to the COVID-19 vaccine, 5 million of these doses have been provided to COVAX facilities. Through the COVAX facility, the most needed vaccines will be urgently distributed to low-income countries, including Uganda, through an equitable distribution system that prioritizes timely delivery to those in need. An additional 4 million doses will be shared directly with the required countries.
As part of this, Uganda received 299,520 doses of the Oxford University AstraZeneca vaccine. It was manufactured by Oxford BioMedica in Oxford and packaged in Wrexham, North Wales in August 2021.
This is the first tranche of 100 million vaccines that the UK has promised to share at the G7 in Cornwall last month by Prime Minister Boris Johnson, with 30 million expected to be delivered by the end of the year. is. Of the 100 million doses, at least 80 million will be sent to COVAX and the rest will be sent directly to the country. Donations follow the pledge made by G7 leaders to immunize the world and end the pandemic in 2022.
This deployment has helped meet the urgent need for vaccines from countries around the world, including Africa, which continues to experience high levels of COVID-19 cases, hospitalizations and deaths.
Former Foreign Minister Dominic Raab said:
“The UK is sending 9 million AstraZeneca vaccines, the first batch of 100 million doses we promised, to vaccinate the world’s most vulnerable areas as an urgent matter. We do this to help the most vulnerable people, because we all know that we are not safe until they are safe. “
The UK has been at the forefront of its global response to the COVID-19, including investing £ 90 million to support the development of the Oxford-AstraZeneca vaccine. Over 500 million doses of the Oxford-AstraZeneca vaccine are available worldwide at non-profit prices, two-thirds of which are destined for low- and middle-income countries.
The UK also launched an effort to establish COVAX in 2020, providing a total of £ 548m to fund vaccines for low-income countries. The scheme has vaccinated more than 152 million times in more than 137 countries and regions, including 83 low- and middle-income countries. 65% of the initial vaccine dose was Oxford-AstraZeneca. COVAX aims to provide 1.8 billion vaccines to low-income countries around the world by early 2022.
Health Minister Sajid Javid said:
“This is a pandemic and the COVID-19 vaccine is the best way to protect people and prevent the emergence of new variants. Through the deployment of the vaccine, we make developing countries like the UK. We want to be able to build a barrier against viruses.
“The UK is one of the largest donors to COVAX, and this donation is part of our pledge to send 100 million vaccines to some of the least developed countries in the world.
“The Government has secured sufficient doses for all UK residents, royal territories, and foreign territories to support ongoing vaccination and booster immunization programs.”
Dr. Seth Berkley, CEO of Gavi, the Vaccine Alliance, which co-leads COVAX with the World Health Organization and the Infectious Disease Control Innovation Alliance, said:
“The UK has been a strong supporter since the establishment of COVAX, and this announcement is made at a critical time. Global vaccine demand far exceeds supply and protects millions of the most vulnerable vaccines. On the other hand, higher vaccination rates around the world are one of the best shields against new variants. In this pandemic, no one is safe until everyone is safe. “
Thermene Pangalos, Executive Vice President of Biopharmacy Research and Development at AstraZeneca, said:
“We are on a mission to divert this pandemic every day by providing broad and equitable access to AstraZeneca’s vaccine. More than 80% of the world’s countries are vaccinated. We are proud that two-thirds are supplied to low- and middle-income and low-income countries.
“Close cooperation between the UK Government and academic and industry partners is important to provide vaccines quickly and protect as many people as possible from this deadly virus.”
Kate Airey, High Commissioner for Uganda, UK, said:
“We are pleased that the UK will send an additional 299,520 doses of AstraZeneca vaccine to Uganda to help the most vulnerable and key workers receive prevention with the COVID vaccine. An additional 299,520 doses from the UK will be prioritized. It is used to give a second dose to the more vulnerable and most vulnerable groups (teachers, over 50 years old, and over 18 years old with potential health risks).
“To date, Uganda has received 1,725,280 vaccines through the COVAX scheme. The UK will continue to support COVID response in Uganda and other countries, with more than 100 million worldwide infections in the coming months. We will contribute, advocate more equitable distribution of vaccines worldwide, and help all of us reduce the risk of COVID. “
Dr. Munir Safirdin, UNICEF Representative of Uganda, said:
“The UNICEF Uganda office appreciates the UK’s dose sharing of the 299,520 AZ vaccine. This cargo will arrive in Uganda because the demand for vaccination exceeds the supply of currently available vaccines. Very timely. I urge other countries to share more vaccines with low and middle income countries. No one is safe until everyone is safe. UK, to this contribution appreciate.”
We need to work together to end the pandemic. Only a truly global response can protect medical services and the people on which children depend. In the fight against the time to end the COVID-19 pandemic and vaccinate people, it is important that as many people as possible get as many safe and effective vaccines as possible as soon as possible.
Distributed by the APO Group on behalf of the British High Commission Kampala.
This press release was published by APO. The content is not monitored by the African Business editorial team, and the content has not been checked or validated by the editorial team, proof leader, or fact checker. The publisher is solely responsible for the content of this announcement.
Uganda benefits from donation of COVID-19 vaccine in the UK
Source link Uganda benefits from donation of COVID-19 vaccine in the UK